EA200300998A1 - Способ получения соединений имидазола - Google Patents

Способ получения соединений имидазола

Info

Publication number
EA200300998A1
EA200300998A1 EA200300998A EA200300998A EA200300998A1 EA 200300998 A1 EA200300998 A1 EA 200300998A1 EA 200300998 A EA200300998 A EA 200300998A EA 200300998 A EA200300998 A EA 200300998A EA 200300998 A1 EA200300998 A1 EA 200300998A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methyl
imidazol
chlorophenyl
obtaining compounds
quinolinone
Prior art date
Application number
EA200300998A
Other languages
English (en)
Other versions
EA006770B1 (ru
Inventor
Вальтер Фердинанд Мария Филльер
Руди Лоран Мария Брукс
Стефан Марсель Херман Леэр
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of EA200300998A1 publication Critical patent/EA200300998A1/ru
Publication of EA006770B1 publication Critical patent/EA006770B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)

Abstract

Настоящее изобретение относится к способу получения 4-(3-хлорфенил)-6-[(4-хлорфенил)гидрокси(1-метил-1H-имидазол-5-ил)метил]-1-метил-2(1H)-хинолинона, который включает взаимодействие 6-(4-хлорбензоил)-4-(3-хлорфенил)-1-метил-2(1H)-хинолинона с соединением Cалкиллития, 1-метилимидазолом и три(Cалкил)силилгалогенидом с получением лучшего выхода указанного выше продукта.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200300998A 2001-03-12 2002-03-05 Способ получения соединений имидазола EA006770B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200928 2001-03-12
PCT/EP2002/002459 WO2002072574A1 (en) 2001-03-12 2002-03-05 Process for the preparation of imidazole compounds

Publications (2)

Publication Number Publication Date
EA200300998A1 true EA200300998A1 (ru) 2004-02-26
EA006770B1 EA006770B1 (ru) 2006-04-28

Family

ID=8180004

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300998A EA006770B1 (ru) 2001-03-12 2002-03-05 Способ получения соединений имидазола

Country Status (32)

Country Link
US (1) US6844439B2 (ru)
EP (1) EP1373255B1 (ru)
JP (1) JP4257698B2 (ru)
KR (1) KR100849042B1 (ru)
CN (1) CN1246318C (ru)
AR (1) AR035944A1 (ru)
AT (1) ATE287882T1 (ru)
AU (1) AU2002253101B2 (ru)
BR (1) BRPI0208075B8 (ru)
CA (1) CA2438421C (ru)
CZ (1) CZ300622B6 (ru)
DE (1) DE60202755T2 (ru)
DK (1) DK1373255T3 (ru)
EA (1) EA006770B1 (ru)
EE (1) EE05247B1 (ru)
ES (1) ES2236505T3 (ru)
HK (1) HK1063315A1 (ru)
HR (1) HRP20030695B1 (ru)
HU (1) HU230282B1 (ru)
IL (2) IL157839A0 (ru)
MX (1) MXPA03008205A (ru)
MY (1) MY124838A (ru)
NO (1) NO324954B1 (ru)
NZ (1) NZ528620A (ru)
PL (1) PL208238B1 (ru)
PT (1) PT1373255E (ru)
SI (1) SI1373255T1 (ru)
SK (1) SK287807B6 (ru)
TW (1) TWI249532B (ru)
UA (1) UA74871C2 (ru)
WO (1) WO2002072574A1 (ru)
ZA (1) ZA200307117B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2291455T3 (es) 2001-03-12 2008-03-01 Avanir Pharmaceuticals Compuestos de bencimidazol para modular ige e inhibir la proliferacion celular.
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
JP2007538004A (ja) * 2004-03-18 2007-12-27 ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド シヌクレイノパチーを治療する方法
US7524961B2 (en) 2004-05-03 2009-04-28 Janssen Pharmaceutica, N.V. Diastereoselective addition of lithiated N-methylimidazole on sulfinimines
JP4917022B2 (ja) * 2004-05-03 2012-04-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ６−ブロモ−４−（３−クロロフェニル）−２−メトキシ−キノリンを用いるジアステレオ選択的合成方法
ATE397600T1 (de) 2004-05-03 2008-06-15 Janssen Pharmaceutica Nv Diastereoselektives syntheseverfahren zur herstellung vn imidazolverbindungen
EP1968591A4 (en) 2005-12-23 2010-02-17 Link Medicine Corp TREATMENT OF SYNUCLEINOPATHIES
US8232402B2 (en) * 2008-03-12 2012-07-31 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
KR101044430B1 (ko) * 2009-09-25 2011-06-27 듀오백코리아 주식회사 요추받이를 포함하는 의자의 등 지지 장치
KR101107900B1 (ko) * 2009-10-21 2012-01-25 성용기업 주식회사 의자용 허리지지장치
PT3277842T (pt) 2015-08-17 2019-09-05 Kura Oncology Inc Métodos de tratamento de doentes com cancro usando inibidores da farnesiltransferase
EP3838275A1 (en) 2016-11-03 2021-06-23 Kura Oncology, Inc. Farnesyltransferase inhibitors for use in methods of treating cancer
US10954210B2 (en) 2016-12-08 2021-03-23 Hangzhou Solipharma Co., Ltd. Crystal form of tipifarnib and preparation method and pharmaceutical composition thereof
AU2019270163A1 (en) * 2018-05-18 2020-12-03 Kura Oncology, Inc. Synthesis of tipifarnib

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW349948B (en) 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
SI1162201T1 (sl) * 1995-12-08 2006-08-31 Janssen Pharmaceutica Nv (Imidazol-5-il)metil-2-kinolinonski derivati kot inhibitorji farnezil protein transferaze
TW591030B (en) 1997-03-10 2004-06-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
CA2288140C (en) 1997-04-25 2007-04-03 Janssen Pharmaceutica N.V. Farnesyltransferase inhibiting quinazolinones
JP3495706B2 (ja) * 1998-08-27 2004-02-09 ファイザー・プロダクツ・インク 抗癌薬として有用なアルキニル置換キノリン−２−オン誘導体
ES2237125T3 (es) 1998-08-27 2005-07-16 Pfizer Products Inc. Derivados de quinolin-2-ona utiles como agentes anticancerigenos.

Also Published As

Publication number Publication date
CN1496363A (zh) 2004-05-12
CZ300622B6 (cs) 2009-07-01
NO20034003L (no) 2003-10-22
WO2002072574A1 (en) 2002-09-19
MY124838A (en) 2006-07-31
US20040138256A1 (en) 2004-07-15
SK12462003A3 (sk) 2004-06-08
MXPA03008205A (es) 2004-01-29
BRPI0208075B8 (pt) 2021-05-25
KR20030079971A (ko) 2003-10-10
HK1063315A1 (en) 2004-12-24
ZA200307117B (en) 2004-09-13
CA2438421A1 (en) 2002-09-19
PT1373255E (pt) 2005-05-31
HRP20030695B1 (en) 2011-07-31
NO20034003D0 (no) 2003-09-10
HRP20030695A2 (en) 2005-02-28
SI1373255T1 (ru) 2005-08-31
SK287807B6 (sk) 2011-10-04
HUP0303443A3 (en) 2012-09-28
TWI249532B (en) 2006-02-21
NO324954B1 (no) 2008-01-14
CZ20032704A3 (en) 2004-03-17
AR035944A1 (es) 2004-07-28
HUP0303443A2 (hu) 2004-01-28
AU2002253101B2 (en) 2007-08-09
CA2438421C (en) 2010-05-18
IL157839A (en) 2008-07-08
PL363263A1 (en) 2004-11-15
IL157839A0 (en) 2004-03-28
EE200300442A (et) 2003-12-15
EP1373255A1 (en) 2004-01-02
JP2004523575A (ja) 2004-08-05
DE60202755D1 (de) 2005-03-03
EP1373255B1 (en) 2005-01-26
BR0208075A (pt) 2004-03-02
CN1246318C (zh) 2006-03-22
PL208238B1 (pl) 2011-04-29
DK1373255T3 (da) 2005-05-23
EE05247B1 (et) 2009-12-15
KR100849042B1 (ko) 2008-07-29
ES2236505T3 (es) 2005-07-16
ATE287882T1 (de) 2005-02-15
BRPI0208075B1 (pt) 2018-02-14
US6844439B2 (en) 2005-01-18
DE60202755T2 (de) 2006-03-30
JP4257698B2 (ja) 2009-04-22
NZ528620A (en) 2005-01-28
UA74871C2 (en) 2006-02-15
EA006770B1 (ru) 2006-04-28
HU230282B1 (hu) 2015-12-28

Similar Documents

Publication Publication Date Title
EA200300998A1 (ru) Способ получения соединений имидазола
MA41338B1 (fr) Composés de pyrazine pour le traitement de maladies infectieuses
FR15C0008I2 (fr) Derive de benzoylpyridine ou sel de ce derive, fongicide le renfermant comme ingredient actif, son procede de production, et produit intermediaire pour sa production
IL281196A (en) Process for the preparation of methyl 6-(4,2-dichlorophenyl)-5-[4-[(S3)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-9,8-dihydro-H7-benzo[ 7]Anolene-2-carboxylate
MY126069A (en) Anticancer compound and enantiomer separation method useful for synthesizing said compound
EA200400953A1 (ru) Замещённые пиридиноны в качестве модуляторов map-киназы p38
NO20060544L (no) Enzymatiske prosesser for produksjon av 4-substituerte 3-hydroksysmorsyrederivater og naerliggende cyano, hydroksy substituerte karboksylsyre estere
WO2002096361A3 (en) 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
NO20054452D0 (no) Fremgangsmate for fremstilling av 5-[(R)-2-(5,6-dietyl-indan-2-ylamino)-1-hydroksyetyl]-8-hydroksy-(1H)-kinolin-2-on-salt som er nyttig som adrenoreseptoragonist
MA27926A1 (fr) Derives de quinoline et de quinazoline presentant une affinite vis-a-vis des recepteurs du type 5ht1
Gerpe et al. Naftifine-analogues as anti-Trypanosoma cruzi agents
RU2006146632A (ru) Производные хиназолинона, полезные в качестве ванилоидных антагонистов
ATE447957T1 (de) Verfahren zur unterdrückung einer immunantwort oder zur behandlung von proliferativen erkrankungen
ATE373009T1 (de) Verfahren zur vorbereitung von telithromycin
TN2010000130A1 (fr) Derives de quinazolinedione, leur preparation et leurs applications therapeutiques
MA29464B1 (fr) Methode de preparation d'acides 1,6-dihydro-6-oxo-4-pyrimidinecarboxyliques eventuellement 2-substitues
MA37649B1 (fr) Procédé de fabrication de composés cyclopentylpyrimidines hydroxylées
WO2007041112A3 (en) Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
WO2004046101A3 (en) Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors
EA201100696A1 (ru) 1-(арилсульфонил)-4-(пиперазин-1-ил)-1h-бензимидазолы в качестве лигандов 5-гидрокситриптамина-6
EA201990652A1 (ru) Фармацевтическая композиция, содержащая два различных активных ингредиента, и способ ее получения
WO2007127479A3 (en) Triaryl substituted imidazole derivatives and taste-inhibiting uses thereof
DE60213802D1 (de) Cak inhibitoren und deren verwendungen
DE602005007346D1 (de) Diastereoselektives syntheseverfahren zur herstellung vn imidazolverbindungen
ATE471316T1 (de) Diastereoselektives syntheseverfahren mit 6-brom- 4-(3-chlorphenyl)-2-methoxychinolin

Legal Events

Date Code Title Description
MK4A Patent expired

Designated state(s): AM AZ BY KZ KG MD TJ TM RU